BMC Genomics (Apr 2009)

Activation of p53-regulated pro-apoptotic signaling pathways in PrP-mediated myopathy

  • Wang Meiling,
  • Huang Shenghai,
  • Landry Laura,
  • Sorensen Garrett,
  • Medina Sarah,
  • Parchaliuk Debra,
  • Liang Jingjing,
  • Kong Qingzhong,
  • Booth Stephanie A

DOI
https://doi.org/10.1186/1471-2164-10-201
Journal volume & issue
Vol. 10, no. 1
p. 201

Abstract

Read online

Abstract Background We have reported that doxycycline-induced over-expression of wild type prion protein (PrP) in skeletal muscles of Tg(HQK) mice is sufficient to cause a primary myopathy with no signs of peripheral neuropathy. The preferential accumulation of the truncated PrP C1 fragment was closely correlated with these myopathic changes. In this study we use gene expression profiling to explore the temporal program of molecular changes underlying the PrP-mediated myopathy. Results We used DNA microarrays, and confirmatory real-time PCR and Western blot analysis to demonstrate deregulation of a large number of genes in the course of the progressive myopathy in the skeletal muscles of doxycycline-treated Tg(HQK) mice. These include the down-regulation of genes coding for the myofibrillar proteins and transcription factor MEF2c, and up-regulation of genes for lysosomal proteins that is concomitant with increased lysosomal activity in the skeletal muscles. Significantly, there was prominent up-regulation of p53 and p53-regulated genes involved in cell cycle arrest and promotion of apoptosis that paralleled the initiation and progression of the muscle pathology. Conclusion The data provides the first in vivo evidence that directly links p53 to a wild type PrP-mediated disease. It is evident that several mechanistic features contribute to the myopathy observed in PrP over-expressing mice and that p53-related apoptotic pathways appear to play a major role.